Literature DB >> 22249317

Surveillance of late-onset bleb leak, blebitis and bleb-related endophthalmitis--a UK incidence study.

A Alwitry1, A J King.   

Abstract

AIMS: To determine the incidence of late-onset bleb leak (BL), blebitis (B) and bleb-related endophthalmitis (BRE) after trabeculectomy surgery, and report the management approaches employed by UK ophthalmologists.
METHODS: Prospective case ascertainment study reporting of incident cases fulfilling the study definitions of BL, B and BRE through the reporting mechanism provided by the British Ophthalmic Surveillance Unit (BOSU; United Kingdom) for the period July 2007 to August 2008 (13 months). Two questionnaires completed at initial reporting and 6 months later were used to collect clinical details related to presentation, early and late management and outcome.
RESULTS: Ninety-eight cases were reported to the British Ophthalmic Surveillance Unit during the study period. Seventy-one first questionnaires were returned (response rate 72.4%). Of these, 11 were erroneous/duplicated. Sixty second questionnaires were sent out, and of these 37 fully completed questionnaires were returned. Analysis was, therefore, based upon 60 initial and 37 follow-up questionnaires. Overall incidences were estimated for isolated bleb leak (0.22%), blebitis without bleb leak (0.1%), blebitis with bleb leak (0.11%), and BRE with or without bleb leak (0.17%). Visual outcome in the BL group was good; however, in the BRE group half the patients ended with visions of perception of light or worse. There was a great variance in the initial and late management of these conditions. Surgical intervention for bleb leak seemed to result in the best chance of leak closure.
CONCLUSIONS: These complications of trabeculectomy surgery are relatively low but potentially visually devastating. This study updates the knowledge of the incidence of these complications, and suggests that no consistent management approach to any of the reported conditions was practised. In view of the potentially catastrophic consequences of these complications, formal guidance as to best practice would be beneficial, and further research to establish this is required.

Entities:  

Mesh:

Year:  2012        PMID: 22249317     DOI: 10.1007/s00417-011-1920-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Late-onset bleb leakage.

Authors:  Donald L Budenz; Nathan Radcliffe; Eytan Z Blumenthal
Journal:  J Glaucoma       Date:  2009-03       Impact factor: 2.503

2.  Recent trends in the rate of trabeculectomy in England.

Authors:  T D L Keenan; C J Wotton; M J Goldacre
Journal:  Eye (Lond)       Date:  2011-06-17       Impact factor: 3.775

3.  Late-onset bleb leaks after glaucoma filtering surgery.

Authors:  D S Greenfield; J M Liebmann; J Jee; R Ritch
Journal:  Arch Ophthalmol       Date:  1998-04

4.  Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont.

Authors:  R L Vogt; D LaRue; D N Klaucke; D A Jillson
Journal:  Am J Public Health       Date:  1983-07       Impact factor: 9.308

5.  Excisional bleb revision to correct overfiltration or leakage.

Authors:  J S Myers; C B Yang; L W Herndon; R R Allingham; M B Shields
Journal:  J Glaucoma       Date:  2000-04       Impact factor: 2.503

6.  Risk factors for glaucoma filtering bleb infections.

Authors:  J B Soltau; R F Rothman; D L Budenz; D S Greenfield; W Feuer; J M Liebmann; R Ritch
Journal:  Arch Ophthalmol       Date:  2000-03

7.  Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study.

Authors:  Tetsuya Yamamoto; Yasuaki Kuwayama
Journal:  Ophthalmology       Date:  2010-10-08       Impact factor: 12.079

8.  Hospital Episode Statistics and changing trends in glaucoma surgery.

Authors:  S G Fraser; R P L Wormald
Journal:  Eye (Lond)       Date:  2006-05-19       Impact factor: 3.775

9.  Surgical repair of leaking filtering blebs.

Authors:  R A Wadhwani; A R Bellows; B T Hutchinson
Journal:  Ophthalmology       Date:  2000-09       Impact factor: 12.079

10.  Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.

Authors:  Peter W DeBry; Todd W Perkins; Gregg Heatley; Paul Kaufman; Lyndia C Brumback
Journal:  Arch Ophthalmol       Date:  2002-03
View more
  7 in total

1.  [Endophthalmitis].

Authors:  Thomas Neß
Journal:  Ophthalmologe       Date:  2018-08       Impact factor: 1.059

2.  Management strategies to reduce risk of postoperative infections.

Authors:  Anat Galor; Raquel Goldhardt; Sarah R Wellik; Ninel Z Gregori; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2013-12

3.  Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS).

Authors:  Sarwar Zahid; David C Musch; Leslie M Niziol; Paul R Lichter
Journal:  Am J Ophthalmol       Date:  2012-12-13       Impact factor: 5.258

Review 4.  Endophthalmitis: state of the art.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Krishna Kishor; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-01-08

5.  Incidence of bleb-associated endophthalmitis in the United States.

Authors:  Kamyar Vaziri; Krishna Kishor; Stephen G Schwartz; Arindel S Maharaj; Darius M Moshfeghi; Andrew A Moshfeghi; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-02-12

6.  Bleb related infections: clinical characteristics, risk factors, and outcomes in an Asian population.

Authors:  Zhu Li Yap; You Chuen Chin; Judy Yu-Fen Ku; Tat Keong Chan; Gillian Teh; Monisha Esther Nongpiur; Tin Aung; Shamira A Perera
Journal:  Clin Ophthalmol       Date:  2016-11-18

7.  Preliminary results of CO2 laser-assisted sclerectomy surgery (CLASS) in the treatment of advanced glaucoma in a Chinese population.

Authors:  Doris W F Yick; Jacky W Y Lee; Susanna Tsang; Barry Y M Yeung; Can Y F Yuen
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.